Skip to content

Advertisement

Molecular Autism

Research
Open Access

Increased copy number for methylated maternal 15q duplications leads to changes in gene and protein expression in human cortical samples

  • Haley A Scoles1,
  • Nora Urraca2,
  • Samuel W Chadwick1,
  • Lawrence T Reiter2, 3 and
  • Janine M LaSalle1Email author
Molecular Autism20112:19

https://doi.org/10.1186/2040-2392-2-19

©  Scoles et al; licensee BioMed Central Ltd. 2011

Received: 17 September 2011

Accepted: 12 December 2011

Published: 12 December 2011

Abstract

Background

Duplication of chromosome 15q11-q13 (dup15q) accounts for approximately 3% of autism cases. Chromosome 15q11-q13 contains imprinted genes necessary for normal mammalian neurodevelopment controlled by a differentially methylated imprinting center (imprinting center of the Prader-Willi locus, PWS-IC). Maternal dup15q occurs as both interstitial duplications and isodicentric chromosome 15. Overexpression of the maternally expressed gene UBE3A is predicted to be the primary cause of the autistic features associated with dup15q. Previous analysis of two postmortem dup15q frontal cortical samples showed heterogeneity between the two cases, with one showing levels of the GABAA receptor genes, UBE3A and SNRPN in a manner not predicted by copy number or parental imprint.

Methods

Postmortem human brain tissue (Brodmann area 19, extrastriate visual cortex) was obtained from 8 dup15q, 10 idiopathic autism and 21 typical control tissue samples. Quantitative PCR was used to confirm duplication status. Quantitative RT-PCR and Western blot analyses were performed to measure 15q11-q13 transcript and protein levels, respectively. Methylation-sensitive high-resolution melting-curve analysis was performed on brain genomic DNA to identify the maternal:paternal ratio of methylation at PWS-IC.

Results

Dup15q brain samples showed a higher level of PWS-IC methylation than control or autism samples, indicating that dup15q was maternal in origin. UBE3A transcript and protein levels were significantly higher than control and autism in dup15q, as expected, although levels were variable and lower than expected based on copy number in some samples. In contrast, this increase in copy number did not result in consistently increased GABRB3 transcript or protein levels for dup15q samples. Furthermore, SNRPN was expected to be unchanged in expression in dup15q because it is expressed from the single unmethylated paternal allele, yet SNRPN levels were significantly reduced in dup15q samples compared to controls. PWS-IC methylation positively correlated with UBE3A and GABRB3 levels but negatively correlated with SNRPN levels. Idiopathic autism samples exhibited significantly lower GABRB3 and significantly more variable SNRPN levels compared to controls.

Conclusions

Although these results show that increased UBE3A/UBE3A is a consistent feature of dup15q syndrome, they also suggest that gene expression within 15q11-q13 is not based entirely on copy number but can be influenced by epigenetic mechanisms in brain.

Keywords

autismimprintingcopy number variation15qduplicationmethylationepigenetic

Background

Autism is a common neurodevelopmental disorder affecting 1 in 110 children [1], but its genetic etiology is complex and heterogeneous [2, 3] Among the leading genetic causes of autism are abnormalities in proximal chromosome 15q, collectively referred to as "duplication 15 syndrome" (dup15q), which occur in ~1-3% of autism cases [4–6]. Dup15q syndrome is a clinically heterogeneous neurodevelopmental disorder characterized by varying degrees of cognitive impairment, gross motor delays, seizures, dysmorphic features and autism in 85% of cases [5, 7, 8].

Chromosome 15q11-q13 is a genetic hotbed for neurodevelopmental disorders because of a high density of low copy repeats (LCRs) that increase susceptibility to errors in meiotic recombination, resulting in deletions as well as duplications [9, 10]. The parental origin of deletions and duplications influences the expression of 15q11-q13 through genomic imprinting. Imprinting of 15q11-q13 is regulated by the bipartite imprinting center (IC), which contains a differentially methylated region at the 5' end of SNRPN that controls expression throughout 15q11-q13 [11]. Loss of 15q11-q13 paternally expressed genes through deletions or maternal uniparental disomy (UPD) results in Prader-Willi syndrome (PWS), whereas the maternal deficiency at this locus results in a phenotypically distinct neurodevelopmental disorder, Angelman syndrome (AS).

Maternally derived duplications of chromosome 15, specifically 15q11-q13, are associated with an autistic phenotype, whereas paternally derived duplications primarily show normal phenotypes but may manifest neurological features other than autism [7, 12]. In addition, individuals with PWS with maternal UPD show a higher occurrence of autism compared to those with PWS 15q11-q13 deletions [13, 14], suggesting that overexpression at maternally expressed genes confers risk for autism [13, 15]. The E3 ubiquitin ligase gene (UBE3A) is the only known paternally imprinted gene in the locus, and its maternal allele-specific transcription is limited to postnatal neurons [16, 17]. While ATP10A was previously described as maternally expressed [18, 19], recent studies have shown variable imprinting in humans and lack of imprinting in mouse [20, 21]. Paternally expressed genes within 15q11-q13 include the splicing factor encoding SNRPN, necdin (NDN), MAGEL2 and several large clusters of small nucleolar RNAs (snoRNAs). A cluster of three receptor subunit genes for the neurotransmitter GABAA (GABRB3, GABRA5, GABRG3) are biallelically expressed in control brain tissue samples, but show epigenetic alterations that result in monoallelic expression in a subset of autism cortical samples [22].

Although increased copy number is generally assumed to increase transcript levels, the epigenetic and neurodevelopmental complexities associated with 15q11-q13 confound this simple explanation of UBE3A overexpression as the sole molecular cause of the dup15q phenotype. In addition to imprinting, the 15q11-q13 locus is subject to the interchromosomal higher organization of homologous pairing between maternal and paternal alleles [23–25]. Chromosome 15 duplications result in disrupted homologous pairing in dup15q brain tissue samples [26] and a neuronal cell line model of dup15q [24]. In addition, disruption of 15q11-q13 pairing by dup15q in neurons has been shown to result in reduced transcript levels of NDN, SNRPN, GABRB3 and CHRNA7[24]. In a prior analysis of two dup15q cortical tissue samples, one showed reduced levels of the paternally derived transcripts SNRPN, snoRNAs, NDN and the biallelically expressed GABRB3, GABRA5 and GABRG3 transcripts that corresponded to PWS-like behaviors [26].

To further understand the genetic and epigenetic effects on transcript levels that lead to the pathogenesis of dup15q syndrome, we performed an extensive analysis of a panel of eight dup15q cortical tissue samples as compared to control and idiopathic autism samples. The dup15q samples showed changes in both methylation and transcription levels, with UBE3A showing significantly higher, SNRPN showing significantly lower and GABRB3 showing variable transcript levels as compared to controls. Interestingly, UBE3A transcript positively correlated with maternal allele-specific methylation of the Prader-Willi imprinting control locus (PWS-IC) within the dup15q samples. These results support the hypothesis that elevated UBE3A levels in the brain are a major contributor to the dup15q phenotype but also are consistent with observations that dup15q syndrome results in transcriptional and epigenetic changes that are variable and not based solely on copy number.

Methods

RNA extraction and cDNA synthesis

Frozen cerebral cortex samples from Brodmann area 19 (BA19) were obtained through the Autism Tissue Program from the University of Maryland Brain and Tissue Bank for Neurodevelopmental Disorders, the Harvard Brain and Tissue Resource Center and the University of Miami Brain and Tissue Bank for Neurodevelopmental Disorders. Brain tissues were stored at -80°C until processing. While the tissues were kept frozen on dry ice, 0.1 to 0.15 g was sliced and homogenized using TRIzol reagent (Invitrogen/Life Technologies, Carlsbad, CA, USA). All RNA work was done on a bench using pipettes wiped down with Ambion RNaseZap wipes (Invitrogen/Life Technologies, Austin, TX, USA) prior to beginning work to prevent RNase contamination of the sample. To eliminate DNA contamination, the RNA was treated with DNase I (New England Biolabs, Ipswich, MA, USA) according to the manufacturer's instructions and precipitated using sodium acetate and ethanol. Single-stranded cDNA was synthesized using QuantiTect Reverse Transcription Kit (QIAGEN, Valencia, CA, USA) and incubated for 15 minutes at 42°C followed by 15 minutes at 50°C with a 3-minute deactivation step at 95°C. For each reaction, a tube without RT was used as a control for genomic DNA contamination. After completion, each reaction was diluted 4.75-fold with DNase- and RNase-free water.

Quantitative RT-PCR

Primers were designed using mRNA sequences extracted from the UCSC Genome Browser [27] with the February 2009 human reference sequence (GRCh37). Primers were designed to cross an intron or span intron-exon boundaries to limit genomic DNA contamination using Primer3 software [28] or Biosearch Technologies RealTimeDesign software (Biosearch Technologies Inc, Novato, CA, USA; http://www.biosearchtech.com/realtimedesign). These primer sequences are shown in Additional file 1. Each reaction was carried out in triplicate, and outliers were removed according to the method described by Bookout et al.[29]. PCR amplification of cDNA was performed using 200 nM primers and EXPRESS SYBR GreenER Universal Master Mix (Invitrogen/Life Technologies). Cycling conditions were 20 seconds at 95°C followed by 40 cycles of 2 seconds at 95°C and 30 seconds at 60°C. The reaction was performed using the Mastercycler ep realplex real-time PCR system (Eppendorf, Hamburg, Germany), and crossing points were analyzed using Realplex software. For each reaction, we ran a well of no RT and no cDNA control to evaluate genomic DNA contamination, nonspecific product formation or other contamination. Reaction conditions were as follows: 1× EXPRESS SYBR GreenER Universal Master Mix, 200 nM primers and 3.5 μl of cDNA. Cycling conditions were as follows: All samples were normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) using the comparative cycle threshold (CT) method (Applied Biosystems, Foster City, CA, USA) to measure fold changes relative to the calibrator, following normalization to GAPDH. Melting curve analysis was also performed to determine homogeneous product formation with no primer-dimers and no nonspecific products.

Quantitative PCR for copy number analysis

Genomic DNA was isolated from brain tissue samples by using the Gentra Puregene Tissue Kit (QIAGEN). PCR conditions were the same as described above using primers shown in Additional file 1.

Determination of methylation percentage at the imprinting center

Methylation-sensitive high-resolution melting-curve analysis (MS-HRM) was performed as described by Urraca et al.[30]. Briefly, 500 ng of DNA was treated with bisulfite. The treated sample (50 ng) was then used for MS-HRM on the LightCycler 480 Real-Time PCR System (Roche Applied Science, Indianapolis, IN, USA) using primers and conditions previously described [30]. Since the paternal SNRPN IC allele is completely unmethylated and the maternal allele is methylated, the normalized fluorescence intensity reveals the percentage of methylated (maternal) to unmethylated (paternal) allele present in a given sample. Additional copies of a maternal duplication of this region results in a higher percentage of maternal allele-specific (methylated) fluorescent signal.

Protein level analyses

Protein extracts were isolated from the same frozen brain tissue samples using TRIzol reagent and analyzed for UBE3A and GABRB3 levels as described previously [31].

Results

Quantitative determination of genomic copy number and PWS-IC methylation in human brain samples

To understand the relationship between increased maternal copy number of chromosome 15 and transcript levels in brain, frozen postmortem brain tissue samples from eight dup15q syndrome, twenty-one control and ten idiopathic autism human cortex tissue samples were obtained from BA19. Figure 1 documents the age, gender and expected 15q copy number extracted from Autism Tissue Program records. The chromosome 15 duplication and expected copy number were confirmed by quantitative PCR (qPCR) performed on genomic DNA from brain tissue samples at three loci (SNRPN, UBE3A and GABRB3) compared to an unduplicated control locus, B2M. Figure 2 shows the expected copy number and parental expression patterns of the three subtypes of dup15q in the collection of brain samples. Six of the dup15q samples showed twofold (2.10 ± 0.14, mean ± SEM) higher levels of 15q loci compared to control samples as expected for typical isodicentric 15q (idic15) duplications (Figure 2b). Case 6294 was confirmed as an interstitial 15q11-q13 duplication (int dup(15)) with 1.5-fold higher copy number as compared to controls with a total of three copies to each control's two (Figure 2c). Case 7014 has been described previously by both fluorescence in situ hybridization and array-comparative genomic hybridization as having a tricentric derivative of chromosome 15 [32], and qPCR confirmed a threefold excess of the three loci compared to controls (Figures 1 and 2d).
Figure 1
Figure 1

Characteristics of individual postmortem human cortex tissue samples and experimental outcomes. Age and gender are listed with the sample number (M, male; F, female). The expected genetic ratio is the number of maternal copies of 15q11-q13 to paternal copies (M:P). The percentage maternal allele-specific methylation in the fluorescent signal for both maternal and paternal melting peaks at the imprinting center of the Prader-Willi locus by methylation-sensitive high-resolution melting-curve analysis is shown in column 5 and then converted to a M:P ratio in column 6. Column 7 shows the M:P methylation ratio after normalization to control brain, with the average control (CTRL) set to 1.0. Columns 8 to 10 show the individual transcript levels normalized to CTRL brain. Protein levels are listed in columns 11 and 12. Each individual transcript and protein level was compared to the expected number of expressed copies relative to unaffected CTRL brain tissues. The data in columns 7 to 12 were then color-coded with a heat map used to visualize the fold changes as higher or lower than expected based on copy number and parental origin. Red is higher than and purple is lower than expected by copy number, with each intensity increase giving a 20% increase or decrease, respectively. *Case 7041 came from an individual who was on a respirator just prior to sample collection.

Figure 2
Figure 2

Diagrams of chromosome 15q11-q13 gene order and expected expression patterns in duplication of 15q11-q13 (dup15q) and control samples based on copy number and parental origin. The paternal chromosome is shown in blue and the maternal chromosome in red. Genes are listed and color blocks match, respectively, to model the location on the chromosome with the orientation indicated by arrows. Red × marks represent silencing from parental imprinting. The table at the top lists total genomic copies and the number of copies of each gene and color code: small nucleoriboprotein N (SNRPN), green; ubiquitin ligase 3A (UBE3A), yellow; and GABAA receptor β3 (GABRB3), purple. (a) Control (CTRL), (b) interstitial duplication of 15q (int dup(15q)) has one additional copy, (c) isodicentric duplication of chromosome 15 (idic(15q)) has two additional maternal copies of the locus and (d) the tricentric supernumerary chromosome 15, which contains four additional copies of chromosome 15.

Although maternally inherited of dup15q is much more common in autism cases, paternally derived duplications may also lead to phenotypic effects, including, but not exclusive to, autism [4]. Therefore, to verify the parental origin of the chromosome 15 duplication in each sample, analysis of the methylation status of the PWS-IC was performed by MS-HRM on the PCR product of bisulfite-converted DNA [30]. This method quantitates the percentage maternal vs paternal (that is, methylated DNA vs unmethylated DNA) at the PWS-IC. The ratio of methylated to unmethylated alleles is a clear indicator of the parental origin of the duplication because a higher methylated fluorescent signal means that more maternal (methylated) DNA than paternal DNA (unmethylated) is present, with the caveat that the 15q duplications have no IC defects, which could result in incomplete or inappropriate methylation of the SNRPN locus [30]. The ratio of maternal to paternal chromosomal copies (M:P) can be calculated by this method, given that the paternal PWS-IC is always unmethylated and the maternal PWS-IC is always methylated in normally developing controls (reviewed in [30]). Unexpectedly, this method revealed higher methylation levels in brain compared to blood samples that we previously analyzed at this locus, with an average of 61.7% (1.6:1 M:P ratio) in control brain compared to 52% previously observed in blood [30]. Brain tissue samples from idiopathic autism subjects exhibited methylation ratios similar to controls, with 61.3% methylation and a M:P ratio of 1.6:1. The observed methylation ratios were then "brain-normalized" to the average control maternal methylation percentage to give an average 1:1 M:P ratio for controls, which adjusted the average dup15q M:P ratio to 2.9:1 (Figure 1, column 7). Both observed and normalized methylation ratios were higher in all eight chromosome 15 duplication samples, confirming the maternal origin of the additional 15q alleles (Figure 3). There was some variation in the percentage methylation in the 3:1 expected ratio class, but this type of variation was also observed in the 2:1 ratio int dup(15) blood samples [30].
Figure 3
Figure 3

The percentage of methylated imprinting center of the Prader-Willi locus (PWS-IC) shows a positive correlation with copy number at the 15q locus. (a) Example of methylation-sensitive high-resolution melting-curve analysis showing > 80% methylated PWS-IC for duplication of 15q11-q13 (dup15q) sample 7041 (3:1 expected genetic ratio of the number of maternal copies of 15q11-q13 to paternal copies (M:P)) and sample 7014 (5:1 expected M:P ratio) (blue curves). All control and autism samples showed, on average, a 62% methylated PWS-IC (sample 6184 autism (orange) and sample 1649 control (green) here). The Prader-Willi syndrome uniparental disomy (PWS-UPD) (yellow) and the Angelman syndrome (AS) deletion (dark red) are shown as indicators of completely unmethylated (AS del) or completely methylated (PWS-UPD) signals from the PWS-IC. The blue arrows show the determination of percentage methylation from the percentage relative signal y-axis. (b) This graph presents the normalized methylation ratio (M:P) shown in Figure 1 grouped by genotype. Note that both control and autism samples cluster tightly at the 1:1 ratio in all samples. There was a single interstitial duplication sample (predicted 2:1 ratio) and a single complex isodicentric 15q (idic15) duplication sample (predicted 5:1 ratio), though the majority of cases examined were idic15q with four copies of the locus (predicted 3:1 ratio). Although somewhat variable, the mean ratio for the Dup 3:1 samples was approximately 3:1 and significantly different from both controls (P = 0.0037) and autism cases (P = 0.0035) by t-test using Welch's correction. The individual Dup 2:1 and Dup 5:1 samples showed higher and lower than predicted ratios, respectively. Error bars represent SEM. There was a positive correlation between the percentage methylation of the PWS-IC and the number of copies of the 15q region, which contains the PWS-IC, on the basis of simple regression analysis (P < 0.001).

Quantitation of UBE3A, SNRPN and GABRB3 transcript levels

To determine the effect dup15q and PWS-IC methylation may have on the transcript levels of the genes within this duplicated region, qRT-PCR was performed on RNA samples isolated from each brain tissue sample. Three chromosome 15 transcripts were amplified, including maternally expressed UBE3A, paternally expressed SNRPN and biallelically expressed GABRB3 (shown in Figure 2). The results were normalized to the chromosome 12 housekeeping control gene GAPDH by using the comparative CT method. The transcript levels, described as fold changes from average control, are shown for each brain tissue sample in Figure 1, columns 8 to 10. To visualize the direction and level of change from the expected transcript levels, heat map colors in Figure 1 were utilized, in which red is higher, purple is lower and white is < 20% change from expected.

The imprinted gene UBE3A is expressed from the maternally derived duplication in addition to the normally inherited maternal chromosome. Idic15, int dup15 and the tricentric duplication would be expected to show 3×, 2× and 5× the number of expressed copies compared to both control and idiopathic autism, respectively (Figure 2). UBE3A transcript was significantly increased in dup15q samples compared to both the control group and autism (P = 0.004 and P = 0.045, respectively) (Figure 4a). In addition, the variability in UBE3A transcript levels between individual dup15q samples was significantly greater than in control or idiopathic autism samples (P = 0.002 and P = 0.045, respectively; Levene's test for equality of variances) (Figures 4a and 4d). When only samples with the same copy number (M:P ratio 3:1) were analyzed, UBE3A levels were an average twofold higher rather than the expected threefold (Additional file 2). When analyzed individually, five of the dup15q samples exhibited UBE3A levels higher than controls, whereas the other three dup15q samples showed levels similar to the control samples (Figure 4d). One idic15 sample (sample 7436) showed UBE3A transcript levels equivalent to the number of maternal copies (three) of UBE3A (Figure 1, column 8, and Figure 4d). However, the level of expression did not linearly correlate with the number of copies of the maternal allele present, with most dup15q samples showing lower UBE3A levels than expected (Figures 1 and 4d). These results indicate that elevated UBE3A levels are present in the brains of dup15q individuals, but that the levels are variable and generally lower than expected.
Figure 4
Figure 4

Transcript level analyses of ubiquitin ligase 3A ( UBE3A ), GABA A receptor β3 ( GABRB3 ) and small nucleoriboprotein N ( SNRPN ) in postmortem human brain tissue. (a) through (c) box-and-whisker plots diagramming transcript levels in postmortem human brain normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH). (a) UBE3A showed a significant increase in mean values for duplication of 15q11-q13 (dup15q) compared to control (CTRL) and autism (AUT). (b) GABRB3 was lower in AUT than in CTRL, whereas dup15q samples showed a significantly increased variance compared with both AUT and CTRL. (c) SNRPN expression levels were significantly lower in dup15q than in the other groups. In addition, AUT showed significantly increased variance for SNRPN levels compared to CTRL and dup15q. Significant differences are indicated by *P < 0.05, **P < 0.01 and ***P < 0.001. Significant differences in the variance between groups were determined by Levene's test for equality of variances, which are represented in blue. Black represents significant differences in the group means as determined by t-test. (d) through (f) Histograms representing the distribution of transcript levels in individual postmortem human brain grouped by condition are shown.

GABRB3 is biallelically expressed, so the idic15, int dup(15) and tricentric derivative chromosome M:P ratios were expected to be 2:1, 1.5:1 and 3:1, respectively, compared to control samples (Figure 2). GABRB3 levels in the dup15q cortex samples instead were highly variable, as three samples showed 0.3× lower expression and five samples showed 1.5× higher GABRB3 levels compared with typically developing controls (Figures 1, 4b and 4e). Figure 4b shows that the biallelically expressed GABRB3 exhibited no significant changes in the quantity of transcript in dup15q samples as a group; however, the variance in GABRB3 was significantly different from both the control group (P < 0.001) and the autism group (P < 0.001; t-test). Figure 4e of the distribution of GABRB3 levels shows two groups of dup15q samples clustered as either higher or lower than control samples. The idiopathic autism group showed a significant reduction in GABRB3 transcript compared with controls as reported previously [22].

SNRPN is paternally expressed and in all cases has one expressed copy, because all of the chromosome 15 duplications used were maternally derived. Surprisingly similar to an idic15 brain sample we previously reported from an individual with PWS-like features [26]. SNRPN was lower than expected by at least 0.77× in six of eight dup15q samples (Figures 1 and 4f) and significantly lower in dup15q samples compared to control or autism samples (Figure 4c). SNRPN levels were reduced from control in sample 6856 and increased from control in sample 7436, similar to findings of the previous study of BA9 prefrontal cortex [26]. Idiopathic autism showed no significant change in SNRPN level, but did show an increase in variability of the ten samples compared to control (P = 0.006; Levene's test for equality of variances) and to dup15q (P = 0.045; Levene's test for equality of variances).

Correlation analyses of 15q transcript and protein levels with copy number and maternal PWS-IC methylation

As UBE3A, GABRB3 and SNRPN were expressed at lower levels than predicted by copy number and parental origin in dup15q brain, we sought to determine whether the transcript levels for genes within the dup15q locus correlate with the number of gene copies. UBE3A and GABRB3 would both be expected to show a positive correlation with the number of gene copies, because the duplication is maternally derived. A significant positive correlation in GABRB3 and UBE3A transcript levels was observed with increased chromosomal copies when all cases (control, autism and dup15q) were analyzed as a group (Figures 5a and 5b). This finding was not significant for the dup15q cases analyzed separately, although the positive trend was apparent (Additional file 3). SNRPN is paternally expressed and was therefore expected to show no correlation with the number of maternal copies of 15q; however, it showed a significant negative correlation of transcript with copy number for all cases (Figure 5c), but the correlation was not significant in the individually analyzed dup15q group (Additional file 3).
Figure 5
Figure 5

Correlation analyses of 15q11-q13 copy number and transcript levels. The relationship between the number of genomic copies of 15q11-q13 and transcript levels in all cases showed a predictive positive correlation with GABAA receptor β3 (GABRB3) (a) and ubiquitin ligase 3A (UBE3A) (b), but a negative correlation with small nucleoriboprotein N (SNRPN) (c). Significance was calculated by simple regression analysis. Diamond, duplication of 15q11-q13; triangle, autism; square, control.

As expected on the basis of the maternal origin of the duplication, 15q11-q13 copy number correlated significantly with percentage PWS-IC methylation (Figure 3). UBE3A transcript level was significantly correlated with increased PWS-IC methylation for all samples (Figure 6a) and for the dup15q samples grouped separately (Figure 6b). When the control and autism cases were analyzed separately, however, no significant correlation between PWS-IC methylation and UBE3A was observed (Additional file 4). GABRB3 also significantly positively correlated with percentage PWS-IC methylation for all cases (Figure 6c). Unlike UBE3A, though, there was no significant correlation with percentage methylation in the dup15q cases grouped separately or with the control or autism cases alone (Additional file 5). In contrast to both UBE3A and GABRB3, SNRPN levels were significantly negatively correlated with percentage PWS-IC methylation in all cases (Figure 6d) but not with dup15q, control or autism cases analyzed separately (Additional file 6).
Figure 6
Figure 6

Ubiquitin ligase 3A ( UBE3A ) and GABA A receptor β3 ( GABRB3 ) levels positively correlate with imprinting center of the Prader-Willi locus (PWS-IC) methylation while small nucleoriboprotein N ( SNRPN ) levels negatively correlate with PWS-IC methylation. A significant positive correlation between PWS-IC methylation and UBE3A transcript levels was observed when all cases were grouped together (a) or for duplication of 15q11-q13 (dup15q) samples only (b). There was no significant correlation between percentage maternal allele-specific methylation at the PWS-IC and levels of UBE3A when cases were grouped separately without duplications as control or autism (Additional file 4). The percentage methylation of PWS-IC correlated with an increase in GABRB3 in all cases (c). When separated by diagnosis, however, the positive trend between GABRB3 and PWS-IC methylation in dup15q, control, or autism cases analyzed separately did not reach significance (Additional file 5). A significant negative correlation between SNRPN and PWS-IC methylation was observed for all cases (d); however, no significant correlation was observed for dup15q, control, or autism samples grouped separately for comparison of SNRPN and PWS-IC methylation (Additional file 6). Significance was calculated by a simple regression analysis. Diamond, dup15q; triangle, autism; square, control.

Protein was isolated from the same tissue as RNA and DNA from each brain sample to determine whether protein levels of 15q transcripts were significantly different between brain sample types or correlated with other measurements. Western blot analyses are only semiquantitative, thus, compared with qRT-PCR, we observed a larger variability between control samples (P = 0.02; Levene's test for equality of variances). Similarly to the transcript analyses, a significantly higher protein level of UBE3A was observed between control and dup15q (Figure 7a), but GABRB3 protein showed no significant differences between dup15q and control or autism samples (Figure 7b). No differences in variability within groups were observed at the GABRB3 protein level (Additional file 7), unlike our observations of GABRB3 transcript levels. At the protein level, both UBE3A and GABRB3 showed no significant relationship with copy number (Additional file 8) or percentage methylation of the PWS-IC (Additional files 9 and 10). The results therefore show that increased expression of both UBE3A transcript and UBE3A protein is a consistent feature of dup15q cortex.
Figure 7
Figure 7

Analysis of ubiquitin ligase 3A (UBE3A) and GABA A receptor β3 (GABRB3) protein levels in postmortem human brain samples. Box-and-whisker plots diagramming protein levels in postmortem human brain tissue normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) by Western blot analysis with a significant increase of UBE3A protein level in duplication of 15q11-q13 (dup15q) (a) and no significant change in GABRB3 protein levels (b). Significant differences are indicated by *P < 0.05 and **P < 0.01. Significant differences in the group means were determined by t-test. Distribution histograms of protein levels of individual brain tissue samples are shown in Additional file 7.

Discussion

This paper reports the largest study of dup15q brain samples to date. Our results demonstrate that duplication of the 15q11-q13 region alters the expression not only of UBE3A, as expected, but also the expression of SNRPN and GABRB3 in ways not always predicted by copy number, confirming our prior small-scale study [26]. Previously, UBE3A overexpression from the duplicated maternal allele had been hypothesized to be the sole explanation for autism comorbidity in dup15q syndrome as well as the increase in autism spectrum disorder (ASD) phenotypes in PWS maternal UPD compared to deletion cases [13, 33]. It is important to keep in mind that the PWS-IC is methylated on all maternal alleles, regardless of allele copy number [34]. Even in studies of various nonneuronal cell lines, however, where UBE3A is expressed biallelically, increases in UBE3A transcript in the dup15q cells were observed [34–36]. Our study replicates the prior findings of increased UBE3A levels in human cortex, showing a twofold increase in dup15q samples. In contrast, GABRB3 expression was not analyzed in any of the prior studies in cell lines, because GABRB3 is a neuronally expressed gene. SNRPN is expressed in nonneuronal cell lines, but researchers in prior studies did not find SNRPN levels to be different from those of controls in nonneuronal cells [34–36]. In our investigation of dup15q human cortex samples, however, SNRPN levels were significantly lower than in controls, a result that we did not expect, since all of the samples (control, autism and dup15) should express one copy of the SNRPN gene from the single paternal allele present. Our results therefore demonstrate the tissue-specific epigenetic complexities associated with dup15q syndrome in humans which simple copy number changes are inadequate to explain.

Epigenetic patterns and mechanisms are often tissue-specific, and the brain shows high levels of DNA methylation despite being primarily nonmitotic in postnatal life [37]. Our recent genomic analysis of DNA methylation showed large genomic regions that are highly methylated in neurons compared to fibroblasts that span large regions of 15q11-q13 [38]. Interestingly, in this study, we observed tissue-specific differences in PWS-IC methylation between brain tissues as compared to blood samples analyzed previously [30] by MS-HRM, with brain tissue showing a higher percentage of baseline maternal allele-specific methylation in controls. The MS-HRM analysis of the PWS-IC upstream of SNRPN showed that, when normalized to brain, a M:P methylation ratio of 2.9:1 was observed, indicating that the duplications are maternal in origin. The increased methylation observed in dup15q samples is consistent with findings of previous studies in blood from int dup(15) samples showing that the duplication is maternal, not paternal, in origin. However, it is possible that the paternal allele may be methylated at one or more individual bases in the dup15q samples only. The recent discovery of 5-hydroxymethylcytosine (5-hmC) [39, 40] may be of significance in this regard, because more 5-hmC has been found in brain than in other tissues [41] and 5-hmC is thought to affect gene regulation through DNA demethylation [42] or by converting 5-methylcytosine (5-mC) to 5-hmC [43–45]. Further investigation of the methylation status of the PWS-IC in brain samples is needed to determine whether the bisulfite-converted sites are protected by 5-hmC or 5-mC.

UBE3A transcript and protein levels were increased twofold on average in dup15q samples compared to controls in our study, consistent with the hypothesis that there is increased maternal allele-specific expression of UBE3A in dup15q autism brain. These levels were slightly lower than expected from maternally expressed genes with an average of three maternal alleles, but this may reflect the complex transcriptional and posttranslational regulation of UBE3A. The function of UBE3A as a transcriptional coactivator has been largely unexplored in the context of human genetic disease, but, in a Drosophila model of 15q duplication syndrome, elevated levels of an enzymatically defective version of Dube3a were able to induce transcription of the dopamine regulator GTP cyclohydrolase I and elevate dopamine levels in the fly brain [46]. UBE3A can trans-ubiquitinate itself in vivo, leading to self-degradation, supporting the idea that there is an upper limit for UBE3A protein induction that may be reached in as few as two active copies of the duplicated region.

Dup15q sample 6,856 showed a 2.5-fold increase in UBE3A compared to no significant change as seen previously for a different brain region from this individual [26]. Brain region differences in transcript levels within the same individual may explain some of the clinical heterogeneity seen within the dup15q syndrome. They may also potentially be explained by the stochastic nature of the epigenetic dysregulation. Interestingly, the epigenetic measure that best correlated with UBE3A levels in the dup15q brain samples was the level of PWS-IC methylation. Since the correlation was positive rather than negative, we hypothesize that maternal PWS-IC methylation acts as a long-range enhancer of UBE3A expression. The methyl-binding protein MeCP2 binds to the methylated PWS-IC allele [25, 31, 47, 48], and MECP2 mutation has been shown to correspond with reduced UBE3A and GABRB3 levels in human brain [31]. Therefore, increased binding of MeCP2 to highly methylated PWS-IC in brain may act as a positive transcriptional regulator of UBE3A and, to a lesser extent, GABRB3 in human cortex.

In contrast to UBE3A, GABRB3 exhibited no significant change in the mean expression in the dup15q cortical samples compared to controls. Instead, significant variability in GABRB3 levels, as well as an interesting bimodal separation in GABRB3 levels of the dup15q samples, was observed in dup15q samples. This result is similar to our findings in a prior study of two samples with discordant GABRB3 levels [26], as well as the finding of reduced GABRB3 levels in 56% of autism cortex samples [22]. SNRPN levels were decreased overall in all dup15q samples in this study, which deviates from our previous study result from sample 7014 at a different brain region, BA9, examined previously [26]. This unexpected result of reduced SNRPN in dup15q postmortem cortex samples suggests that an increase in maternal dosage of the region epigenetically affects transcription of a paternally expressed gene, possibly in a tissue- or region-specific manner. In contrast to UBE3A and GABRB3, which positively correlated with PWS-IC methylation, SNRPN levels showed a negative correlation with PWS-IC methylation. These results suggest that although maternal methylation of the PWS-IC is repressive to SNRPN expression, as expected, there appears to be a long-range enhancing effect of PWS-IC methylation on UBE3A and GABRB3. Homologous chromosome pairing of maternal and paternal 15q11-q13 alleles occurs in human lymphocytes, neuronal cells and brain [23–25]. Both dup15q brain samples and a neuronal cell culture model of dup15q in SH-SY5Y neuronal cells showed significant disruption of homologous pairing that corresponded to reduced SNRPN and lower than expected GABRB3 levels [24, 26].

Conclusions

This study, together with previous studies of dup15q syndrome, shows that dup15q brain samples are epigenetically complex and that 15q11-q13 transcripts in brain do not behave solely as predicted by copy number. These findings should be important for understanding ASD cases with other de novo copy number variations on other chromosomes, in particular large duplications [49]. The bimodal pattern of GABRB3 deficiencies seen in these 8 dup15q samples may provide some insight into the relationship between dup15q and seizures. Maternal UPD PWS individuals have a higher incidence of seizures than individuals with deletions [14], suggesting that these people may also have epigenetically induced GABRB3 deficiency. GABRB3 and UBE3A are well-characterized candidate genes for ASD because they are associated with normal brain development and have been shown to be reduced in idiopathic autism, Angelman syndrome and Rett syndrome [31]. Although these results provide support for the hypothesis that overexpression of the maternally expressed UBE3A gene in the brain is the primary underlying cause of the ASD phenotype in dup15q, the changes in GABRB3 and SNRPN expression not predicted by copy number may also influence the phenotypic variability observed in ASD.

Abbreviations

AS: 

Angelman syndrome

dup15q: 

duplication of 15q11-q13

IC: 

imprinting control locus

idic15: 

isodicentric 15q

int dup(15): 

interstitial duplication 15q

GABA: 

γ-aminobutyric acid

GABRB3: 

GABAA receptor β3

GAPDH: 

glyceraldehyde 3-phosphate dehydrogenase

LCR: 

low copy repeat

MS-HRM: 

methylation-sensitive high-resolution melting-curve analysis

PWS: 

Prader-Willi syndrome

PWS-IC: 

imprinting center of the Prader-Willi locus

RT-PCR: 

reverse transcriptase polymerase chain reaction

snoRNA: 

small nucleolar RNA

SNRPN: 

small nucleoriboprotein N

UBE3A: 

ubiquitin ligase 3A

UPD: 

uniparental disomy.

Declarations

Acknowledgements

We are grateful to all of the families who donated the tissues that made this study possible. This work was supported by National Institutes of Health awards R01 HD048799, 2R01HD041462, and R01 NS076263 (to JML), a Shainberg Neuroscience Fund award (to LTR) and a University of Tennessee Health Science Center Neuroscience Institute Fellowship (to NA).

Authors’ Affiliations

(1)
Medical Microbiology and Immunology, Genome Center, and Medical Institute of Neurodevelopmental Disorders, One Shields Avenue, University of California, Davis, Davis, USA
(2)
Department of Neurology, University of Tennessee Health Science Center, Memphis, USA
(3)
Department of Pediatrics, University of Tennessee Health Science Center, Memphis, USA

References

  1. Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ. 2009, 58: 1-20.Google Scholar
  2. Bill BR, Geschwind DH: Genetic advances in autism: heterogeneity and convergence on shared pathways. Curr Opin Genet Dev. 2009, 19: 271-278. 10.1016/j.gde.2009.04.004.PubMed CentralView ArticlePubMedGoogle Scholar
  3. Bourgeron T: A synaptic trek to autism. Curr Opin Neurobiol. 2009, 19: 231-234. 10.1016/j.conb.2009.06.003.View ArticlePubMedGoogle Scholar
  4. Depienne C, Moreno-De-Luca D, Heron D, Bouteiller D, Gennetier A, Delorme R, Chaste P, Siffroi JP, Chantot-Bastaraud S, Benyahia B: Screening for Genomic Rearrangements and Methylation Abnormalities of the 15q11-q13 Region in Autism Spectrum Disorders. Biol Psychiatry. 2009Google Scholar
  5. Schroer RJ, Phelan MC, Michaelis RC, Crawford EC, Skinner SA, Cuccaro M, Simensen RJ, Bishop J, Skinner C, Fender D, Stevenson RE: Autism and maternally derived aberrations of chromosome 15q. Am J Med Genet. 1998, 76: 327-336. 10.1002/(SICI)1096-8628(19980401)76:4<327::AID-AJMG8>3.0.CO;2-M.View ArticlePubMedGoogle Scholar
  6. Battaglia A: The inv dup (15) or idic (15) syndrome (Tetrasomy 15q). Orphanet J Rare Dis. 2008, 3: 30-10.1186/1750-1172-3-30.PubMed CentralView ArticlePubMedGoogle Scholar
  7. Cook EH, Lindgren V, Leventhal BL, Courchesne R, Lincoln A, Shulman C, Lord C, Courchesne E: Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am J Hum Genet. 1997, 60: 928-934.PubMed CentralPubMedGoogle Scholar
  8. Battaglia A: The inv dup(15) or idic(15) syndrome: a clinically recognisable neurogenetic disorder. Brain & development. 2005, 27: 365-369. 10.1016/j.braindev.2004.08.006.View ArticleGoogle Scholar
  9. Christian SL, Fantes JA, Mewborn SK, Huang B, Ledbetter DH: Large genomic duplicons map to sites of instability in the Prader-Willi/Angelman syndrome chromosome region (15q11-q13). Hum Mol Genet. 1999, 8: 1025-1037. 10.1093/hmg/8.6.1025.View ArticlePubMedGoogle Scholar
  10. Makoff AJ, Flomen RH: Detailed analysis of 15q11-q14 sequence corrects errors and gaps in the public access sequence to fully reveal large segmental duplications at breakpoints for Prader-Willi, Angelman, and inv dup(15) syndromes. Genome Biol. 2007, 8: R114-10.1186/gb-2007-8-6-r114.PubMed CentralView ArticlePubMedGoogle Scholar
  11. Sutcliffe JS, Nakao M, Christian S, Orstavik KH, Tommerup N, Ledbetter DH, Beaudet AL: Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nat Genet. 1994, 8: 52-58. 10.1038/ng0994-52.View ArticlePubMedGoogle Scholar
  12. Wahlstrom J, Steffenburg S, Hellgren L, Gillberg C: Chromosome findings in twins with early-onset autistic disorder. Am J Med Genet. 1989, 32: 19-21. 10.1002/ajmg.1320320105.View ArticlePubMedGoogle Scholar
  13. Milner KM, Craig EE, Thompson RJ, Veltman MW, Thomas NS, Roberts S, Bellamy M, Curran SR, Sporikou CM, Bolton PF: Prader-Willi syndrome: intellectual abilities and behavioural features by genetic subtype. J Child Psychol Psychiatry. 2005, 46: 1089-1096. 10.1111/j.1469-7610.2005.01520.x.View ArticlePubMedGoogle Scholar
  14. Veltman MW, Thompson RJ, Roberts SE, Thomas NS, Whittington J, Bolton PF: Prader-Willi syndrome--a study comparing deletion and uniparental disomy cases with reference to autism spectrum disorders. Eur Child Adolesc Psychiatry. 2004, 13: 42-50. 10.1007/s00787-004-0354-6.View ArticlePubMedGoogle Scholar
  15. Bolton PF, Dennis NR, Browne CE, Thomas NS, Veltman MW, Thompson RJ, Jacobs P: The phenotypic manifestations of interstitial duplications of proximal 15q with special reference to the autistic spectrum disorders. Am J Med Genet. 2001, 105: 675-685. 10.1002/ajmg.1551.View ArticlePubMedGoogle Scholar
  16. Rougeulle C, Glatt H, Lalande M: The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain [letter] [In Process Citation]. Nat Genet. 1997, 17: 14-15. 10.1038/ng0997-14.View ArticlePubMedGoogle Scholar
  17. Yamasaki K, Joh K, Ohta T, Masuzaki H, Ishimaru T, Mukai T, Niikawa N, Ogawa M, Wagstaff J, Kishino T: Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a. Hum Mol Genet. 2003, 12: 837-847. 10.1093/hmg/ddg106.View ArticlePubMedGoogle Scholar
  18. Kashiwagi A, Meguro M, Hoshiya H, Haruta M, Ishino F, Shibahara T, Oshimura M: Predominant maternal expression of the mouse Atp10c in hippocampus and olfactory bulb. J Hum Genet. 2003, 48: 194-198. 10.1007/s10038-003-0009-3.View ArticlePubMedGoogle Scholar
  19. Meguro M, Kashiwagi A, Mitsuya K, Nakao M, Kondo I, Saitoh S, Oshimura M: A novel maternally expressed gene, ATP10C, encodes a putative aminophospholipid translocase associated with Angelman syndrome. Nat Genet. 2001, 28: 19-20.PubMedGoogle Scholar
  20. DuBose AJ, Johnstone KA, Smith EY, Hallett RA, Resnick JL: Atp10a, a gene adjacent to the PWS/AS gene cluster, is not imprinted in mouse and is insensitive to the PWS-IC. Neurogenetics. 11: 145-151.Google Scholar
  21. Hogart A, Patzel KA, Lasalle JM: Gender influences monoallelic expression of ATP10A in human brain. Hum Genet. 2008Google Scholar
  22. Hogart A, Nagarajan RP, Patzel KA, Yasui DH, Lasalle JM: 15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders. Hum Mol Genet. 2007, 16: 691-703.PubMed CentralView ArticlePubMedGoogle Scholar
  23. LaSalle J, Lalande M: Homologous association of oppositely imprinted chromosomal domains. Science. 1996, 272: 725-728. 10.1126/science.272.5262.725.View ArticlePubMedGoogle Scholar
  24. Meguro-Horike M, Yasui DH, Powell W, Schroeder DI, Oshimura M, Lasalle JM, Horike SI: Neuron-specific impairment of inter-chromosomal pairing and transcription in a novel model of human 15q-duplication syndrome. Hum Mol Genet. 2011Google Scholar
  25. Thatcher K, Peddada S, Yasui D, LaSalle JM: Homologous pairing of 15q11-13 imprinted domains in brain is developmentally regulated but deficient in Rett and autism samples. Hum Mol Genet. 2005, 14: 785-797. 10.1093/hmg/ddi073.View ArticlePubMedGoogle Scholar
  26. Hogart A, Leung KN, Wang NJ, Wu DJ, Driscoll J, Vallero RO, Schanen NC, LaSalle JM: Chromosome 15q11-13 duplication syndrome brain reveals epigenetic alterations in gene expression not predicted from copy number. J Med Genet. 2009, 46: 86-93.PubMed CentralView ArticlePubMedGoogle Scholar
  27. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D: The human genome browser at UCSC. Genome Res. 2002, 12: 996-1006.PubMed CentralView ArticlePubMedGoogle Scholar
  28. Rozen S, Skaletsky H: Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 2000, 132: 365-386. Source code available at http://frodo.wi.mit.edu/primer3/PubMedGoogle Scholar
  29. Bookout AL, Cummins CL, Mangelsdorf DJ, Pesola JM, Kramer MF: High-throughput real-time quantitative reverse transcription PCR. Curr Protoc Mol Biol. 2006, Chapter 15 (Unit 15): 18-Google Scholar
  30. Urraca N, Davis L, Cook EH, Schanen NC, Reiter LT: A single-tube quantitative high-resolution melting curve method for parent-of-origin determination of 15q duplications. Genet Test Mol Biomarkers. 2010, 14: 571-576. 10.1089/gtmb.2010.0030.PubMed CentralView ArticlePubMedGoogle Scholar
  31. Samaco RC, Hogart A, LaSalle JM: Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum Mol Genet. 2005, 14: 483-492.PubMed CentralView ArticlePubMedGoogle Scholar
  32. Mann SM, Wang NJ, Liu DH, Wang L, Schultz RA, Dorrani N, Sigman M, Schanen NC: Supernumerary tricentric derivative chromosome 15 in two boys with intractable epilepsy: another mechanism for partial hexasomy. Hum Genet. 2004, 115: 104-111.View ArticlePubMedGoogle Scholar
  33. Steffenburg S, Gillberg C, Hellgren L, Andersson L, Gillberg IC, Jakobsson G, Bohman M: A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry. 1989, 30: 405-416. 10.1111/j.1469-7610.1989.tb00254.x.View ArticlePubMedGoogle Scholar
  34. Herzing LBK, Cook EH, Ledbetter DH: Allele-specific expression analysis by RNA-FISH demonstrates preferential maternal expression of UBE3A and imprint maintenance within 15q11-q13 duplications. Hum Mol Genet. 2002, 11: 1707-1718. 10.1093/hmg/11.15.1707.View ArticlePubMedGoogle Scholar
  35. Baron CA, Tepper CG, Liu SY, Davis RR, Wang NJ, Schanen NC, Gregg JP: Genomic and functional profiling of duplicated chromosome 15 cell lines reveal regulatory alterations in UBE3A-associated ubiquitin-proteasome pathway processes. Hum Mol Genet. 2006, 15: 853-869. 10.1093/hmg/ddl004.View ArticlePubMedGoogle Scholar
  36. Nishimura Y, Martin CL, Vazquez-Lopez A, Spence SJ, Alvarez-Retuerto AI, Sigman M, Steindler C, Pellegrini S, Schanen NC, Warren ST, Geschwind DH: Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Hum Mol Genet. 2007, 16: 1682-1698. 10.1093/hmg/ddm116.View ArticlePubMedGoogle Scholar
  37. Ehrlich M, Gama-Sosa MA, Huang LH, Midgett RM, Kuo KC, McCune RA, Gehrke C: Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. Nucleic Acids Res. 1982, 10: 2709-2721. 10.1093/nar/10.8.2709.PubMed CentralView ArticlePubMedGoogle Scholar
  38. Schroeder DI, Lott P, Korf I, Lasalle JM: Large-scale methylation domains mark a functional subset of neuronally expressed genes. Genome Res. 2011Google Scholar
  39. Kriaucionis S, Heintz N: The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science. 2009, 324: 929-930. 10.1126/science.1169786.PubMed CentralView ArticlePubMedGoogle Scholar
  40. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, Rao A: Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 2009, 324: 930-935. 10.1126/science.1170116.PubMed CentralView ArticlePubMedGoogle Scholar
  41. Ruzov A, Tsenkina Y, Serio A, Dudnakova T, Fletcher J, Bai Y, Chebotareva T, Pells S, Hannoun Z, Sullivan G: Lineage-specific distribution of high levels of genomic 5-hydroxymethylcytosine in mammalian development. Cell Res. 2011Google Scholar
  42. Guo JU, Su Y, Zhong C, Ming GL, Song H: Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell. 2011, 145: 423-434. 10.1016/j.cell.2011.03.022.PubMed CentralView ArticlePubMedGoogle Scholar
  43. Ficz G, Branco MR, Seisenberger S, Santos F, Krueger F, Hore TA, Marques CJ, Andrews S, Reik W: Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature. 2011, 473: 398-402. 10.1038/nature10008.View ArticlePubMedGoogle Scholar
  44. Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y: Role of Tet proteins in 5 mC to 5 hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature. 2010, 466: 1129-1133. 10.1038/nature09303.PubMed CentralView ArticlePubMedGoogle Scholar
  45. Robertson J, Robertson AB, Klungland A: The presence of 5-hydroxymethylcytosine at the gene promoter and not in the gene body negatively regulates gene expression. Biochem Biophys Res Commun. 2011, 411: 40-43. 10.1016/j.bbrc.2011.06.077.View ArticlePubMedGoogle Scholar
  46. Ferdousy F, Bodeen W, Summers K, Doherty O, Wright O, Elsisi N, Hilliard G, O'Donnell JM, Reiter LT: Drosophila Ube3a regulates monoamine synthesis by increasing GTP cyclohydrolase I activity via a non-ubiquitin ligase mechanism. Neurobiol Dis. 41: 669-677.Google Scholar
  47. Makedonski K, Abuhatzira L, Kaufman Y, Razin A, Shemer R: MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression. Hum Mol Genet. 2005, 14: 1049-1058. 10.1093/hmg/ddi097.View ArticlePubMedGoogle Scholar
  48. Yasui DH, Peddada S, Bieda MC, Vallero RO, Hogart A, Nagarajan RP, Thatcher KN, Farnham PJ, Lasalle JM: Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci USA. 2007, 104: 19416-19421. 10.1073/pnas.0707442104.PubMed CentralView ArticlePubMedGoogle Scholar
  49. Morrow EM: Genomic copy number variation in disorders of cognitive development. J Am Acad Child Adolesc Psychiatry. 2010, 49: 1091-1104.PubMed CentralPubMedGoogle Scholar

Copyright

© Scoles et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement

Molecular Autism

ISSN: 2040-2392